Cited by 208Per- and polyfluoroalkyl substances researchPeroxisome Proliferator-Activated ReceptorsEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays

Open access

Evans, Nicola, Conley, Justin M., Cardon, Mary, Hartig, Phillip, Medlock-Kakaley, Elizabeth, Gray, L. Earl·2022·Toxicology and Applied Pharmacology

DOI 10.1016/j.taap.2022.116136PMC PMC9341220

Open this paper in CoChat — free account

Abstract

Data demonstrate numerous per- and polyfluoroalkyl substances (PFAS) activate peroxisome proliferator-activated receptor alpha (PPARα), however, additional work is needed to characterize PFAS activity on PPAR gamma (PPARγ) and other nuclear receptors. We utilized in vitro assays with either human or rat PPARα or PPARγ ligand binding domains to evaluate 16 PFAS (HFPO-DA, HFPO-DA-AS, NBP2, PFMOAA, PFHxA, PFOA, PFNA, PFDA, PFOS, PFBS, PFHxS, PFOSA, EtPFOSA, and 4:2, 6:2 and 8:2 FTOH), 3 endogenous fatty acids (oleic, linoleic, and octanoic), and 3 pharmaceuticals (WY14643, clofibrate, and the metabolite clofibric acid). We also tested chemicals for human estrogen receptor (hER) transcriptional activation. Nearly all compounds activated both PPARα and PPARγ in both human and rat ligand binding domain assays, except for the FTOH compounds and PFOSA. Receptor activation and relative potencies were evaluated based on effect concentration 20% (EC 20), top percent of max fold induction (pmax top), and area under the curve (AUC). HFPO-DA and HFPO-DA-AS were the most potent (lowest EC 20, highest pmax top and AUC) of all PFAS in rat and human PPARα assays, being slightly less potent than oleic and linoleic acid, while NBP2 was the most potent in rat and human PPARγ assays. Only PFHxS, 8:2 and 6:2 FTOH exhibited hER agonism >20% pmax. In vitro measures of human and rat PPARα and PPARγ activity did not correlate with oral doses or serum concentrations of PFAS that induced increases in male rat liver weight from the National Toxicology Program 28-d toxicity studies. Data indicate that both PPARα and PPARγ activation may be molecular initiating events that contribute to the in vivo effects observed for many PFAS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.taap.2022.116136

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
Half-Lives of PFOS, PFHxS and PFOA after End of Exposure to Contaminated Drinking Water
Li, Y., Fletcher, T., Mucs, D., Scott, K., Lindh, C. H., Tallving, P., & Jakobsson, K. (2018) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104651 · Cited by 815
Integrated physiology and systems biology of PPARα
Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.002 · Cited by 701
Legacy and Emerging Perfluoroalkyl Substances Are Important Drinking Water Contaminants in the Cape Fear River Watershed of North Carolina
Sun, M., Arevalo, E., Strynar, M., Lindstrom, A., Richardson, M., Kearns, B., Pickett, A., Smith, C., & Knappe, D. R. U. (2016) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6b00398 · Cited by 688
Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-α, -β, and -γ, Liver X Receptor-β, and Retinoid X Receptor-α
Heuvel, J. P. V., Thompson, J. T., Frame, S. R., & Gillies, P. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl014 · Cited by 489
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (α, β/δ, γ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate
Takacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 388

Show all 72 references

Research works printed but not linked: 1

IARC, 1996, Clofibrate, IARC Monograph, 66, 391

Sorted by citations

Items 101–200 of 208

Association between PFAS exposure and metabolic-related biomarkers in Spanish adolescents
Rodríguez‐Carrillo, A., Vela-Soria, F., Smagulova, F. O., Fernández, M. F., & Freire, C. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121171 · Cited by 6
Poly- and per-fluoroalkyl substances toxicity on skeletal and cognitive well-being: a comprehensive review
Roy, V. C., Bala, R., & Mehta, S. (2025) · Journal of Environmental Science and Health Part C · doi:10.1080/26896583.2025.2460884 · Cited by 6
The effects of acute and chronic exposure to bisphenols and PFAS on neuronal activity and network development
van Melis, L. V. J., Persad, A. R., Peerdeman, A. M., van Rossum, M. J. H., van Kleef, R. G. D. M., Wopken, J. P., Legler, J., & Westerink, R. H. S. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180214 · Cited by 6
Per- and Polyfluoroalkyl Substances in Eutopic Endometrium Tissue and Risk of Endometriosis: Findings from the Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) Study
Marroquin, J. M., Krall, J. R., Schliep, K. C., Farland, L. V., Vimalkumar, K., Kannan, K., & Pollack, A. Z. (2025) · Environmental Health Perspectives · doi:10.1289/ehp15852 · Cited by 5
A systems toxicology approach implicates post-transcriptional regulatory networks in reproductive defects from PFAS exposure
Bline, A. P., Jiang, H., Levenson, M. T., & Allard, P. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf111 · Cited by 4
PFOA exposure causes kidney injury via disruption of lipid metabolism mediated by PPARα signaling pathway: An integrated analysis
Wu, Y., Jiang, Y., Fan, Z., Liu, X., Sun, W., Wang, L., & Liu, H. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.111736 · Cited by 5
A randomized controlled trial of a housing intervention to reduce endocrine disrupting chemical exposures in children
Fossa, A. J., Manz, K. E., Papandonatos, G. D., Chen, A., Guardia, M. J. L., Lanphear, B. P., Hale, R. C., Pagano, A., Pennell, K. D., Yolton, K. A., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108994 · Cited by 6
Comparative study on gene expression profiles in the liver of male neonatal mice prenatally exposed to PFOA and its alternative HFPO-DA
Murase, W., Kubota, A., Hakota, R., Yasuda, A., Ikeda, A., Nakagawa, K., Shizu, R., Yoshinari, K., & Kojima, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154048 · Cited by 5
Prenatal Concentrations of Perfluoroalkyl Substances and Maternal Beta Cell Function at 7 to 9 Years of Follow-Up
Palaniyandi, J., Bruin, J. E., Fisher, M. M., Borghese, M. M., Hoyeck, M. P., Panagiotopoulos, C., & Ashley‐Martin, J. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf143 · Cited by 5
Endocrine disruption potential of dust in children's indoor environments: Associations with multiple chemicals from various compound classes across exposure matrices used for health risk assessment
Sjöström, Y., Holmes, B. E., Ricklund, N., Struwe, N., Hagström, K., Hagberg, J., & Larsson, M. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121614 · Cited by 5
Investigating the mode of action for liver toxicity and wasting-like responses produced by high dose exposures to longer chain perfluoroacid substances (PFAS) using high throughput transcriptomicsPreprint
Barutcu, A. R., Black, M. B., & Andersen, M. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.02.583129 · Cited by 5
Per- and Polyfluoroalkyl Substances (PFAS) in Fruit Flies: Environmental Surveillance and Hazard Characterization of “Forever Chemicals”
Yang, J., Wu, J., & Wa̅ng, Y. (2025) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.5c01048 · Cited by 4
Perfluorooctane Sulfonate (PFOS) and Related Compounds Induce Nuclear Receptor 4A1 (NR4A1)-Dependent Carcinogenesis
Hailemariam, A., Upadhyay, S., Srivastava, V. K., Hafiz, Z., Zhang, L., Tsui, W. N. T., Oany, A. R., Rivera-Rodriguez, J., Chapkin, R. S., Riddell, N., et al. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.4c00528 · Cited by 4
Impact of per- and polyfluoroalkyl substances (PFAS) in wild plants, soil and water in two Austrian national parks
Weinbauer, H., Mann, O., & Hornek-Gausterer, R. (2025) · Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180346 · Cited by 4
Receptor-specific inhibition of pro-inflammatory cytokine secretion induced by PFAS in THP1-derived macrophages: a structure-activity relationship study
Amstutz, V. H., Mircheva, A., Cengo, A., Bergsma, C., Sijm, D. T. H. M., & Vrolijk, M. F. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111793 · Cited by 5
The role of lipid metabolism and peroxisome proliferator activation in mediating pro-cancer phenotypes of poly- and perfluoroalkyl substances in testicular cancer
Boyd, R. I., Shokry, D. N. A. M., Rennels, B. C., Adam, Y., Powell, C., Johnson, S., Spinella, M. J., & Singh, R. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104866 · Cited by 4
Per- and polyfluoroalkyl substances in the environment and human tissue: A critical review of distribution, exposure pathways, and health risks
Zhenyu, Liu, Y., Chen, Y., Qu, H., Ma, J., Pang, M., Wang, B., & Yu, G. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127988 · Cited by 8
Development of a QSAR model for predicting PPARα activation by PFAS based on human in vitro data of a comprehensive panel of legacy and novel PFAS
Alker, W., Tsiros, P., Sarimveis, H., Braeuning, A., & Buhrke, T. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04359-2 · Cited by 4
Association Between Prenatal Per- and Polyfluoroalkyl Substance Exposure and Maternal Serum Total Bile Acid Levels During Pregnancy: Effect Modification by Infant Sex and Maternal Prepregnancy BMI
Liao, Q., Huang, H.-S., Tang, P., Liang, J., Chen, J.-H., Lei, L., Song, Y., Pan, D.-X., Lin, M., Lv, F., et al. (2023) · Exposure and Health · doi:10.1007/s12403-023-00588-3 · Cited by 4
PFAS-Biomolecule Interactions: Case Study Using Asclepios Nodes and Automated Workflows in KNIME for Drug Discovery and Toxicology
Papavasileiou, K. D., Tsoumanis, A., Lagarias, P. I., Kolokathis, P. D., Koutroumpa, N.-M., Melagraki, G., & Afantitis, A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4003-6_19 · Cited by 4
Dose–response modeling of effects in mice after exposure to a polyfluoroalkyl substance (Nafion byproduct 2)
Corton, J. C., Gift, J. S., Auerbach, S. S., Liu, J., Das, K. P., Ren, H., Lang, J. R., Chernoff, N., Lau, C. S., & Hill, D. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf042 · Cited by 4
Predicting peroxisome proliferator-activated receptor gamma potency of small molecules: a synergistic consensus model and deep learning binding affinity approach powered by Enalos Cloud Platform
Antoniou, M., Papavasileiou, K. D., Tsoumanis, A., Melagraki, G., & Afantitis, A. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11230-6 · Cited by 5
Potential role of vitamin C in mitigating perfluoroalkyl substances-induced immunotoxicity
Li, R., Huang, R., Qin, F., Qian, N., Qin, M., Ma, W., Lai, K. P., Zeng, X., & Li, R. (2025) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2025.07.024 · Cited by 4
AhR/ROS-mediated endoplasmic reticulum stress contributes to PFOSA-induced cardiac defects
Wang, K., Chen, H., Chen, P., Wu, L., Jiang, Y., & Chen, T. (2025) · Toxicology · doi:10.1016/j.tox.2025.154363 · Cited by 3
Human Exposure Pathways to Per- and Polyfluoroalkyl Substances (PFASs)—A Comprehensive Review of Sources, Physicochemical Properties, and Human Health Risk Assessment
Reindl, A. R., & Zduńczuk, J. A. (2026) · Toxics · doi:10.3390/toxics14060528 · Cited by 3
Prenatal PFAS exposures and cardiometabolic health in middle childhood in the MIREC cohort
Fossa, A. J., Hall, A. M., Papandonatos, G. D., Arbuckle, T. E., Ashley‐Martin, J., Borghese, M. M., Bruin, J., Chen, A., Fisher, M. M., Krzeczkowski, J. E., et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121330 · Cited by 5
An electrochemiluminescence biosensor for the screening of environmental estrogens using a peptide probe targeting the activated estrogen receptor
Li, J., Ding, Y., Ma, J., Liu, C., Li, M., & Guo, L. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122165 · Cited by 3
Xeno-estrogenic activity of real-life mixtures of perfluoroalkylated substances in human placenta homogenates
Wielsøe, M., Molina-Molina, J.-M., Rodríguez‐Carrillo, A., Mustieles, V., Olea, N., Fernández, M. F., & Bonefeld‐Jørgensen, E. C. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108444 · Cited by 3
Relevance of flounder caging and proteomics to explore the impact of a major industrial accident caused by fire on the Seine estuarine water quality
Laurent, J., Diop, M., Amara, R., Fisson, C., Armengaud, J., Labadie, P., Budzinski, H., Couteau, J., Maillet, G., Floch, S. L., et al. (2024) · Marine Pollution Bulletin · doi:10.1016/j.marpolbul.2024.116178 · Cited by 3
Comparative study on the transcriptional activities of grass carp (Ctenopharyngodon idellus) peroxisome proliferator-activated receptors induced by different fatty acids
Tian, Z., Wei, M., Xue, R., Song, L., Li, H., Ji, H. L., PeiZhen, X., & Sun, J. H. (2024) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2024.111021 · Cited by 3
Spatiotemporal map of the developing human reproductive tract at single-cell resolutionPreprint
Lorenzi, V., Icoresi-Mazzeo, C., Yayon, N., Ruiz-Morales, E. R., Sancho‐Serra, C., Wong, F. C. K., Marečková, M., Tuck, E. J., Roberts, K., Li, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.30.621114 · Cited by 3
Neurotoxicity of poly- and perfluoroalkyl substances (PFAS): Epidemiological and rodent studies of behavioral outcomes
O’Shaughnessy, K. L., Oshiro, W. M., Jackson, T. W., Starnes, H. M., Sasser, A. L., & McMichael, B. D. (2023) · Advances in neurotoxicology · doi:10.1016/bs.ant.2023.09.002 · Cited by 2
Exploring the relationship between per- and polyfluoroalkyl substances exposure and rheumatoid arthritis risk using interpretable machine learning
Li, Z., Xu, X., & Zhang, K. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1581717 · Cited by 2
Environmental factors influence goat immune response to PFOS and glyphosate: Difference between grazing and stall-feeding
Molinari, F., Franco, G. A., Inferrera, F., Tranchida, N., Iaconis, A., Rizzo, M. A., Paola, D. D., Piccione, G. G., & Gugliandolo, E. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104754 · Cited by 2
Maternal, fetal, and neonatal toxicity and potency estimates of perfluorohexane sulfonate (PFHxS) from oral maternal exposure in the Sprague-Dawley rat
Conley, J. M., Lambright, C. S., Evans, N., Bangma, J., Ford, J., Hill, D., Medlock-Kakaley, E., & Gray, L. E. (2025) · Toxicology · doi:10.1016/j.tox.2025.154245 · Cited by 2
Self-citation
Human proteome-wide molecular interaction analysis based on AlphaFold3 to evaluate toxicity between PFOS and its alternative F-53B
Li, H., Chen, N., Yu, B., Peng, Y., Yuan, Y., Guo, H., & Zhang, Z. (2025) · Toxicology · doi:10.1016/j.tox.2025.154308 · Cited by 2
Developmental exposure to a PFAS mixture impairs the anamnestic response to influenza A virus infection in mice
Post, C. M., Agyemang, J. J., McDonald, K. A., McDonough, C. A., & Lawrence, B. P. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag058 · Cited by 2
PPAR subtypes determine distinct modes of action of phthalate esters (PAEs) and per- and polyfluoroalkyl substances (PFAS) in disrupting human macrophage alternative activation
Zhuang, Z., You, L., Kong, J., Tian, Y., Li, Y., Zhi, Y., Zhang, B., Wan, Y., Xudong, J., & Yang, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154387 · Cited by 3
PPARs, L-FABP mediate the association between Per- and polyfluoroalkyl substances and gestational diabetes: a nested case-control study
Xiang, Q., Guo, P., Tian, Q., Liang, Y., Zhang, F., Zhuo, L., Yang, Y., Zhao, C., Zhang, Y., & Lei, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-36679-9 · Cited by 2
Forever Chemicals, Finite Defenses: PFAS Burden the Liver, Break Mitochondria, and Outpace Modern Regulation
Goyal, A., Kesmez, M., & Aykin‐Burns, N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062723 · Cited by 2
Bioactivity Classification of 2,649 Per- and Polyfluoroalkyl Substances (PFASs) via Quantitative Structure–Activity Relationships and Molecular Docking to Health-Relevant Proteins
Li, W., & Bischel, H. N. (2026) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.6c00172 · Cited by 2
Dietary Phytochemicals as Multi-Target Defenders Against Plastic-Associated Toxicity
Tkaczenko, H., Kołodziejska, R., Лукаш, О. В., Yakovenko, O., Buyun, L., Kirvel, I., Kamiński, P., & Kurhaluk, N. (2026) · Applied Sciences · doi:10.3390/app16104761 · Cited by 2
Systematic review and Integrated Approaches to Testing and Assessment (IATA) of PFOA and PFOS for endocrine disrupting effects based on the AOP framework
Kim, D., Ji, S., & Park, K. (2025) · Environmental Analysis Health and Toxicology · doi:10.5620/eaht.2025s03 · Cited by 2
Evaluation of Endocrine Disruptome and VirtualToxLab for Predicting Per- and Polyfluoroalkyl Substances Binding to Nuclear Receptors
Franko, N., Vetrih, M., & Dolenc, M. S. (2025) · Journal of Xenobiotics · doi:10.3390/jox15050136 · Cited by 2
Temporal changes in per and polyfluoroalkyl substances and their associations with type 2 diabetes
Berg, V., Charles, D., Huber, S., Nøst, T. H., Sandanger, T. M., Averina, M., Bergdahl, I. A., Nilsen, M. M., Wilsgaard, T., & Rylander, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-05422-1 · Cited by 1
Association Between Per‐ and Polyfluoroalkyl Substances ( PFAS ) Exposure and LDL Cholesterol in US Adults: Evidence From NHANES
Bhagavathula, A. S., Krishnan, D., & Chu, M. B. (2025) · Lipids · doi:10.1002/lipd.70008 · Cited by 1
A comparative toxicological and epidemiological evaluation of dioxins and PFAS chemicals
Paustenbach, D. J., Kissell, K., & Shakya, A. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2560827 · Cited by 1
Sex-Specific associations between per- and polyfluoroalkyl substances (PFAS) exposure and spinal posture in Children: The mediating role of bile acid metabolism
Cao, W., Zhang, L., Zhao, Y., Wang, P., Li, Q., Wang, H., Xu, Y., Wang, M., Wang, F., Shi, H., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109977 · Cited by 1
Per‐ and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative
Driban, J. B., Rokoff, L. B., Lu, B., McAlindon, T. E., Eaton, C. B., Roberts, M. B., Mathes, D., Lestician, C., Xu, Z. C., Fan, Z. T., et al. (2025) · Arthritis & Rheumatology · doi:10.1002/art.70026 · Cited by 1
PFOA and co-exposure with PFOS induce AMPK-dependent hypoglycemia in mice: integrated evidence from physiology, multi-omics, and molecular docking
Chang, J., Xiaojuan, X., Shiyan, C., Xiaoli, Y., Yan, Z., Junfang, Z., Zhiliang, Z., Yin, D., & Yanling, Q. (2026) · Environment International · doi:10.1016/j.envint.2026.110076 · Cited by 1
Identification of functional genetic components modulating toxicity response to PFOS using genome-wide CRISPR screens in HepG2/C3A cells
Kim, C., Tagmount, A., Zhu, Z., Wilson, F., Li, D., Ostrov, D. A., Brad Barbazuk, W., Bacher, R., & Vulpe, C. D. (2026) · Archives of Toxicology · doi:10.1007/s00204-025-04294-8 · Cited by 1
Associations between prenatal and adolescent per- and polyfluoroalkyl substances (PFAS) exposure and pubertal development as well as endocrine hormones in girls from the Sheyang Mini Birth Cohort
Zheng, W., Zhang, B., Li, W., Xu, Y., 常秀丽, Lu, D., Lin, Y., Feng, C., Qi, X., Zhang, J., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.123995 · Cited by 1
Health hazards of per- and polyfluoroalkyl substances via nuclear receptors
Lu, R., Pang, Y., Yu, J., & Zhang, J. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128063 · Cited by 2
A combined in silico and in vitro new approach methodology for early detection of liver steatogenic chemicals
Verhoeven, A., Gadaleta, D., Isbaita, N. H. K., Jiang, J., Sanz-Serrano, J., Serrano‐Candelas, E., Ortega-Vallbona, R., Vanhaecke, T., & Vinken, M. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112153 · Cited by 1
Assessment of the obesogenic properties of PFAS using an in vitro-based testing strategy
Lentz, S. B. I., Bil, W., Bokkers, B. G. H., van Merode, K., Kamstra, J. H., & Legler, J. (2026) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2026.106142 · Cited by 1
Perfluoroalkyl and polyfluoroalkyl substances exposure and liver disease: A review
Peng, J., Gong, R., Li, R., Li, L., Yu, H., & Wen, Q. (2026) · Toxicology · doi:10.1016/j.tox.2026.154509 · Cited by 1
PFAS exposure modulates mitochondrial susceptibility in steatotic hepatocytes
Barbosa, J. M. G., Alijagić, A., Nguyen, A. H., Castro‐Alves, V., Valgueblasse, L., Orešič, M., & Hyötyläinen, T. (2026) · Environment International · doi:10.1016/j.envint.2026.110337 · Cited by 1
PFAS Exposure and Metabolic Disorders: Mechanistic Insights into Lipid and Glucose Homeostasis
Chen, X., Wen, W., Gu, S., Guo, F., Mo, Z., Chen, Z., Yan, S., & Wang, X. F. (2026) · Biomolecules · doi:10.3390/biom16071056 · Cited by 1
Persistent Organic Pollutants and Cardiotoxicity
Djordjević, A. B. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_25 · Cited by 1
Acute PFOS exposure consistently dysregulates glucose-stimulated insulin secretion across model systemsPreprint
Palaniyandi, J., Hoyeck, M. P., Vanzyl, E. J., Basu, L., Ching, M. E. A., Ameyaa-Sakyi, A., Blais, A., Tayabali, A. F., Rand, A. A., & Bruin, J. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.23.684149 · Cited by 1
Subchronic Toxicity Assessment of Perfluoroalkyl Substances by Mixed Exposure of Nine Substances at Daily Intake Relevant ConcentrationPreprint
Takeda, K., Saito, T., Sasaki, S., Eguchi, A., Sugiyama, M., Suzuki, K., Eto, S., & Kamata, R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541082
Metabolic, Neurotoxic and Immunotoxic Effects of Pfaas and Their Mixtures on the Proteome of the Head Kidney and Plasma from Rainbow TroutPreprint
Simmons, D. B. D., Pollard, S., & Silva, A. O. D. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4668629
A High-Throughput Screening Approach for Evaluating the Binding Affinity of Environmental Pollutants to Nuclear Receptors
Sun, L., & Li, C. (2024) · Journal of Visualized Experiments · doi:10.3791/67327
Effects of a novel estrogenic perfluoroalkyl substance on reproductive endocrinology and function in the fathead minnow (Pimephales promelas)
Ankley, G. T., Jensen, K. M., Cavallin, J. E., Baettig, C. G., Balgooyen, S., Blackwell, B. R., Blanksma, C. A., Collins, J., Ellman, M., Hoang, J. X., et al. (2025) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgaf006
PFAS (perfluoroalkyl and polyfluoroalkyl substances) and breast cancer
Wexler, M., Pasquale, A. D., & Moody, H. L. (2024) · doi:10.71450/42501116
Hepatic Effects of PFAS
Woodlief, T. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00278-3
Chemical hazard characterisation of PFAS : current approaches in dose-response assessments and the lipidomic disruption in human cell models
Brunken, L. (2025) · doi:10.69622/28473254.v1
Harnessing Canthium parviflorum for Metabolic Modulation: A Dual Approach of Molecular Docking and In-vitro Insights into Diabetes and Obesity Therapeutics
Kalaivanan, S., & Ranganathan, S. (2025) · Current Bioactive Compounds · doi:10.2174/0115734072372897250625145123
Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances and Gestational Weight Gain: A Systematic Review and Meta-analysis
Halili, A., Kazemzadeh, M., Ahmadieh-Khanehsar, A., & Goodarzi-Khoigani, M. (2025) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_139_24
In vitro confirmation of estrogenic and antiandrogenic pesticide bioactivity using schild regression analysis
Boxberger, C., Gray, L. E., Evans, N., Conley, J. M., & Medlock-Kakaley, E. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117523
Self-citation
Effect of the perfluorooctane sulfonamide on glucose and lipid metabolism in 3T3-L1 adipocytes and zebrafish larvae
Pech, P., Thakuri, L. S., Min, E. K., Rhyu, D. Y., & Kim, K. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122666
Childhood exposure to per- and polyfluoroalkyl substances during eating activities: Occurrence, exposure, and developmental risk
Shen, X., Xu, C. Y., Yuan, P., Wei, Y., Wei, Y., Wang, W., Li, Y., & Deng, Q. (2025) · Environmental Chemistry and Ecotoxicology · doi:10.1016/j.enceco.2025.10.019
Mixtures of p,p′-DDE, PCB153, BDE47, and PFOS Alter Adipocytic Differentiation of 3T3-L1 Cells
Garcia, M., Pearce, J. L., Jacobellis, M. A., Baldwin, W. S., Hunt, K. J., & Bain, L. J. (2025) · Toxics · doi:10.3390/toxics13110975
Polyfluoroalkyl substances and altered glucose homeostasis in adolescents following bariatric surgery
Costello, E. J., Baumert, B. O., Li, Z., Midya, V., Pan, S., Ryder, J. R., Inge, T. H., Jenkins, T. M., Sisley, S. R., Xanthakos, S. A., et al. (2025) · Environmental Endocrinology · doi:10.1093/enendo/wkaf003
NMR-Based toxicometabolomics of Yellowtail Snapper (Ocyurus chrysurus) embryos, as a relevant ecological receptor, exposed to perfluorooctane sulfonate (PFOS)
Lawson, A., Annunziato, M., Bashirova, N., Eeza, M. N. H., Matysik, J., Stieglitz, J. D., Alia, A., & Berry, J. P. (2026) · Ecotoxicology · doi:10.1007/s10646-026-03057-0
A Genome-Wide CRISPR Screen Identifies C18orf32 as a Novel Modulator of PFOA-Induced Cytotoxicity and Lipid Dysregulation
Kim, C., Tagmount, A., Zhu, Z., Wilson, F., Barbazuk, B., Bacher, R., & Vulpe, C. D. (2026) · Environmental Health Perspectives · doi:10.64898/2025.12.23.696201
A genomic framework for evaluating the impact of per- and polyfluoroalkyl substances on bone health
Liu, S., Luo, S., Zhao, X., Wang, Y., Peng, Y., Liu, J., & He, H. (2026) · Environmental Sciences Europe · doi:10.1186/s12302-025-01303-6
Advances in the Distribution, Transport, and Transformation of PFAS in the Drinking Water System: From Source to Tap
Yang, H., He, W., Li, D., Pan, X., Li, X., Zhu, Q., Xiang, H., & Ouyang, E. (2026) · Water Environment Research · doi:10.1002/wer.70299
Metabolomic Responses to External and Internal Environmental Exposures: Evidence of Lipid and Energy Metabolism Disruption in the Estonian BiobankPreprint
Oosterwegel, M. J., Vermeulen, R. C. H., de Hoogh, K., Hiie, L., Esko, T., Vlaanderen, J. J., & Kronberg, J. (2026) · medRxiv · doi:10.64898/2026.03.17.26347937
Ecologie du stress et qualité écologique de l'estuaire de la Seine et des fleuves côtiers bretons : signatures environnementales et moléculaires chez une espèce sentinelle, le Flet (Platichthys flesus)
Laurent, J. (2023) · theses.fr (ABES) · doi:10.70675/e7897dfazde97z449fzbb47z1ea3e22b5e6c
PFNA dominates the association between PFAS mixture exposure and hypertension risk: The mediating role of estradiol in the U.S. adults
Li, L. H., Li, M., Jiang, J., Wang, J., Zhu, L., Jiang, N., He, X., Liu, H., Wang, S., He, J., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120124 · Cited by 1
Multigenerational toxicity of perfluorooctanoic acid (PFOA) on the demography of Simocephalus vetulus (Branchiopoda)
Zamora-Barrios, C. A., Torner-Morales, F. J., Moreno-Gutiérrez, R. M., Zamora-Vargas, B., Cortés-Lagunes, S., & Cruz-Cano, R. I. (2026) · Ecotoxicology · doi:10.1007/s10646-026-03079-8
PFAS exposure and reproductive dysfunction: implications for outcomes in assisted reproductive technologies
Shu, X., Zhou, W., Zhang, T., Ye, J.-F., Zhao, Y.-J., Gu, C., Yu, Y., & Li, M.-Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1808266
Histopathology and transcriptomics in male zebrafish livers from a perfluorooctanesulfonic acid multigenerational exposure inform adverse outcome pathway development for liver steatosis
Mylroie, J. E., Gust, K. A., Blanksma, C., Lawrence, A. B., Hoke, A. V., Rosales, I. N. C., Wilbanks, M. S., Steward, C., García‐Reyero, N., Gautam, A., et al. (2026) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgag143
Associations between prenatal per- and polyfluoroalkyl substance exposure and maternal fatty acid homeostasis: Nonmonotonic, compartment-specific patterns in plasma and red blood cells
Liao, C., Zhang, Y., Zeng, Y., Liu, P., Zhong, S., Mu, Y., Wu, Y., Li, T., Zhou, Z., & Zhou, Z. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.142843
A systems-level integration of liver-kidney transcriptomics and genome-scale metabolic models reveals organ-specific injury mechanisms
Pannala, V. R., Hari, A., Auerbach, S. S., & Wallqvist, A. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1866643
Per- and polyfluoroalkyl substances exposure and risk of liver cancer: A comprehensive review of epidemiological and mechanistic evidence
Fang, J.-M., Jin, H.-B., Hong, J., Liang, Y., Shu, X., Zheng, S., & Cao, L. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.07.002
Prenatal PFAS exposure and offspring health: evidence review and implications for intergenerational risk assessment
Deng, B., Xia, X., & Sun, X. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1892134
Evaluation of the reproductive toxicity of endocrine disruptors during early embryo development
Parra-Forero, L. Y., & Nowak, R. A. (2026) · Biology of Reproduction · doi:10.1093/biolre/ioag154
Childhood exposure to legacy and emerging per- and polyfluoroalkyl substances and autistic traits in children at age 4
Guo, Y., Ao, J., Tang, W., Liu, X., Liu, J., Zhang, Q., Ge, W., & Li, F. R. (2026) · Environment International · doi:10.1016/j.envint.2026.110427
Structural conservation of peroxisome proliferator–activated receptor isoforms reveals potential of perfluorooctanesulfonic acid to disrupt mammalian and avian lipid signaling
Lenz, B. Q., Ankley, G. T., & Etterson, M. A. (2026) · Environmental Toxicology and Chemistry · doi:10.1093/etojnl/vgag203
Sex-Specific Associations Between Per- and Polyfluoroalkyl Substances and the Risk of Type 2 Diabetes: The Role of Genetic Susceptibility and Lipid Metabolism
Cheng, X., Gao, J., Liu, L., Liu, L., Guo, H., Zhang, J., Wang, Y., Qiu, G., & He, M. (2026) · Environmental Health Perspectives · doi:10.1021/ehp.6c00071
Halogenated bisphenol A alternatives inhibit aldo-keto reductase 1C1 and induce metabolic alterations in human adipocytes
Kleißen, J., Goerdeler, C., Aldehoff, A. S., Karkossa, I., Didio, A., Schmidt, J., Kalkhof, S., Lehmann, J., Rolle-Kampczyk, U. E., Grimaldi, M., et al. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.143238
Novel Perfluoroalkyl Substance GenX exposure promotes non-small cell lung cancer progression by regulating the OTUB1/STAT3/VEGF axis
Wang, H., Chen, Y., xue, Z., Cheng, S., Tian, P., Dong, Y., & Meng, Q. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116307
Per- and Polyfluoroalkyl Substance Exposure, Obesity Patterns, and Hypertension among Young Men
Huang, L., Ji, N., Shao, H., Liu, C., Sun, F., Zhang, Y., Mustieles, V., Gaskins, A. J., Messerlian, C., Pan, A., et al. (2026) · Environment & Health · doi:10.1021/envhealth.6c00091
Integrative network toxicology and molecular docking reveal epigenetic and endocrine-disrupting mechanisms of PFAS in ovarian cancer
Wang, Y., Liu, X., Ding, Y., Zhao, Z., Chen, H., Wu, X., Yang, Y., Pan, P., Li, L., & Gao, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1905013
From Follicle Development to Fertilization: How PCBs and PFAS May Shape Female Reproductive Health
Alam, M. H., Barteld, E. C., Tlapa, J., Ridlon, M., & Keil, K. P. (2026) · Toxics · doi:10.3390/toxics14090780
Embryonic exposure to ambient concentrations of PFAS impairs the innate immune response in zebrafish and fathead minnow
Lyons, S., Yu, A. M., Dehnert, G. K., & Heiden, T. C. K. (2026) · Journal of Immunotoxicology · doi:10.1080/1547691x.2026.2728992
Kidney Risks Linked to Per‐ and Polyfluoroalkyl Substance Exposure
Chávez‐Valencia, V., & Lagunas‐Rangel, F. A. (2026) · Environmental Toxicology · doi:10.1002/tox.70197
Exposition précoce aux perturbateurs endocriniens et développement du surpoids chez l’enfant et l’adolescent : enseignements des études épidémiologiques
Kadawathagedara, M., Ouidir, M., Warembourg, C., & Heude, B. (2026) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2026.09.013

Authors: Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E.
Affiliations: Environmental Protection Agency (US)
Corresponding author: Conley, Justin M.
ORCID: Evans, Nicola
Conley, Justin M.
Medlock-Kakaley, Elizabeth
Gray, L. Earl
Venue: Toxicology and Applied Pharmacology
Publisher: Elsevier BV
Published: 2022-08
Volume: 449
Pages: 116136
ISSN: 0041-008X (ISSN-L)
DOI: 10.1016/j.taap.2022.116136
PMC: PMC9341220
OpenAlex: W4283375803
Cited by: 208
References: 72
Citations by year: 2026: 53 · 2025: 73 · 2024: 51 · 2023: 29 · 2022: 2
FWCI: 13.73
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Toxicology and Applied Pharmacology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Topics: Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords: per- and polyfluoroalkyl substances, PPARα, PPARγ, estrogen receptor, nuclear receptor activation, HFPO-DA, fatty acids, clofibric acid, clofibrate, Wy-14,643, PFOS, PFHxS, molecular initiating events, liver weight, endocrine disruptors
MeSH terms: Animals, Fatty Acids, Female, Fluorocarbons, Ligands, Male, Receptors, Estrogen, PPAR alpha, PPAR gamma, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks